Provided by Tiger Trade Technology Pte. Ltd.

ResMed

233.50
+2.891.25%
Post-market: 233.500.00000.00%16:20 EDT
Volume:928.16K
Turnover:217.00M
Market Cap:34.08B
PE:23.09
High:235.17
Open:233.65
Low:232.00
Close:230.61
52wk High:293.81
52wk Low:199.92
Shares:145.97M
Float Shares:145.51M
Volume Ratio:0.77
T/O Rate:0.64%
Dividend:2.33
Dividend Rate:1.00%
EPS(TTM):10.11
EPS(LYR):9.55
ROE:25.68%
ROA:14.75%
PB:5.39
PE(LYR):24.46

Loading ...

ResMed General Counsel Sells Shares Under Pre-Set Trading Plan

TIPRANKS
·
Feb 09

Resmed Inc-4 Statement of Changes in Beneficial Ownership

THOMSON REUTERS
·
Feb 09

4 Statement of changes in beneficial ownership-RMD.N

Reuters
·
Feb 09

'I'm worried about cash flow': I'm 71 with a $2.7 million IRA and $470K in stocks. Why can't I relax?

Dow Jones
·
Feb 09

ResMed Inc. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
Feb 07

ResMed Inc. Global General Counsel Michael J. Rider Reports Disposal of Common Shares

Reuters
·
Feb 07

ResMed Director Sells 2,000 Shares

MT Newswires Live
·
Feb 06

ResMed Adjusts CDI and Share Balances Amid Ongoing Capital Management

TIPRANKS
·
Feb 05

Statement of CDIs on issue - RMD-RMD.N

Reuters
·
Feb 05

ResMed Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Feb 05

'I'm worried about cash flow': I'm 71 with a $2.7 million IRA and $470K in stocks. Why can't I relax?

Dow Jones
·
Feb 04

ResMed CFO Sells 1,000 Shares Under Pre-Set Trading Plan

TIPRANKS
·
Feb 04

Resmed Inc-4 Statement of Changes in Beneficial Ownership

THOMSON REUTERS
·
Feb 04

ResMed CFO Brett Sandercock Reports Disposal of Common Shares

Reuters
·
Feb 04

ResMed Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Feb 03

ResMed Is Maintained at Buy by Citigroup

Dow Jones
·
Feb 03

ResMed price target raised to $345 from $330 at Citi

TIPRANKS
·
Feb 02

Morgans Financial Upgrades ResMed to Buy from Accumulate, Price Target is AU$47.73

MT Newswires Live
·
Feb 02

ResMed Bull Anticipates Further Buybacks -- Market Talk

Dow Jones
·
Feb 02

ResMed Bull Stays Positive Amid Strong Revenue Growth -- Market Talk

Dow Jones
·
Feb 02